Kaylynn Yoon

Kaylynn Yoon currently serves as Senior Director of Commercial Legal at Alnylam Pharmaceuticals, a position held since June 2023. Prior to this role, Kaylynn worked at Boehringer Ingelheim from July 2021 to June 2023, focusing on legal issues related to the launch of biosimilar products and therapeutic areas including Interstitial Lung Disease and Mental Health. Kaylynn's experience further includes serving as VP of US Commercial Law at Y-mAbs Therapeutics, where leadership was provided for legal, regulatory, and compliance teams, and holding senior legal roles at Bristol Myers Squibb and Celgene, managing legal matters for the Multiple Myeloma franchise. Previous positions also include Senior Director at Bayer overseeing Women's Healthcare legal matters, Regulatory Counsel at the FDA, and an attorney with the U.S. Department of Health and Human Services focusing on the Affordable Care Act. Academic credentials include a BA in Public Health/Natural Sciences from The Johns Hopkins University, a JD from Rutgers Law School, and an MHS in Health Policy & Management from Johns Hopkins Bloomberg School of Public Health.